CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway

Jiangtao Yu1, Xiaoli Hu1, Xiuxiu Chen1

  • 1Department of Gynecology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, People's Republic of China.

Life Sciences
|January 7, 2021
PubMed
Abstract

Insights

CNOT7 promotes ovarian cancer (OC) progression by enhancing cell proliferation, migration, and invasion. Inhibiting CNOT7 or targeting the AKT pathway may offer new therapeutic strategies for OC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • CNOT7 is implicated in various biological processes and presents potential as a therapeutic target for malignant tumors.
  • The specific role and mechanism of CNOT7 in ovarian cancer (OC) remain largely uncharacterized.

Purpose of the Study:

  • To investigate the function and mechanism of CNOT7 in ovarian cancer (OC).

Main Methods:

  • CNOT7 expression was analyzed in OC cell lines (SKOV3, HO8910, A2780) and ovarian surface epithelium (OSE) cells using Western blot and RT-PCR.
  • Cell proliferation, migration, invasion, cell cycle, and apoptosis were assessed following CNOT7 knockdown or overexpression.
  • The impact of AKT inhibitor LY294002 on CNOT7-overexpressing cells was evaluated.

Main Results:

  • CNOT7 expression was significantly elevated in OC cells compared to OSE cells.
  • CNOT7 knockdown inhibited OC cell proliferation, migration, and invasion, while promoting apoptosis and autophagy.
  • CNOT7 overexpression yielded opposite effects, and these effects were partially or fully reversed by LY294002, indicating involvement of the AKT pathway.

Conclusions:

  • CNOT7 exhibits a carcinogenic role in ovarian cancer.
  • The carcinogenic effects of CNOT7 in OC are likely mediated through the AKT signaling pathway.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.8K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
6.0K